Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
E.S. Lander, L.M. Linton, B. Birren, C. Nusbaum, M.C. Zody, J. Baldwin, et al.
Initial sequencing and analysis of the human genome.
Nature, 409 (2001), pp. 860-921
[2.]
A.C. Syvanen.
Accessing genetic variation: genotyping single nucleotide polymorphisms.
Nat Rev Genet, 2 (2001), pp. 930-942
[3.]
G. Gambaro, F. Anglani, A. D'Angelo.
Association studies of genetic polymorphisms and complex disease.
Lancet, 355 (2000), pp. 308-311
[4.]
R. Bataller, K. North.
Genetic polymorphisms and the progression of liver fibrosis: a critical review [en prensa].
Hepatology, (2002),
[5.]
E.E. Powell, C.J. Edwards-Smith, J.L. Hay, A.D. Clouston, D.H. Crawford, C. Shorthouse, et al.
Host genetic actors influence disease progression in chronic hepatitis C.
Hepatology, 31 (2000), pp. 828-833
[6.]
A. Tanaka, S. Quaranta, A. Mattalia, R. Coppel, F. Rosina, M. Manns, et al.
The tumor necrosis factor-alpha promoter correlates with progression of primary biliary cirrhosis.
J Hepatol, 30 (1999), pp. 826-829
[7.]
M. Yamauchi, Y. Maezawa, Y. Mizuhara, M. Ohata, J. Hirakawa, H. Nakajima, et al.
Polymorphisms in alcohol metabolizing enzyme genes and alcoholic cirrhosis in Japanese patients: a multivariate analysis.
Hepatology, 22 (1995), pp. 1136-1142
[8.]
A. Monzoni, F. Masutti, G. Saccoccio, S. Bellentani, C. Tiribelli, M. Giacca.
Genetic determinants of ethanol-induced liver damage.
Mol Med, 7 (2001), pp. 255-262
[9.]
L.G. Carr, J.Y. Hartleroad, Y. Liang, C. Mendenhall, T. Moritz, H. Thomasson.
Polymorphism at the P450IIE1 locus is not associated with alcoholic liver disease in Caucasian men.
Alcohol Clin Exp Res, 19 (1995), pp. 182-184
[10.]
H.A. Jarvelainen, A. Orpana, M. Perola, V.T. Savolainen, P.J. Karhunen, K.O. Lindros.
Promoter polymorphism of the CD14 endotoxin receptor gene as a risk factor for alcoholic liver disease.
Hepatology, 33 (2001), pp. 1148-1153
[11.]
L.J. Yee, J. Tang, A.W. Gibson, R. Kimberly, D.J. Van Leeuwen, R.A. Kaslow.
Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection.
Hepatology, 33 (2001), pp. 708-712
[12.]
B.C. Smith, J. Gorve, M.A. Guzail, C.P. Day, A.K. Daly, A.D. Burt, et al.
Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C.
Hepatology, 27 (1998), pp. 1695-1699
[13.]
A.J. Czaja, S. Cookson, P.K. Constantini, M. Clare, J.A. Underhill, P.T. Donaldson.
Cytokine polymorphisms associated with clinical features and treatment outcome in type 1 autoimmune hepatitis.
Gastroenterology, 117 (1999), pp. 645-652
[14.]
C. Corpechot, P. Benlian, V. Barbu, O. Chazouilleres, R.E. Poupon, R. Poupon.
Apolipoprotein E polymorphism, a marker of disease severity in primary biliary cirrhosis?.
J Hepatol, 35 (2001), pp. 324-328
[15.]
S. Bernard, S. Touzet, I. Personne, V. Lapras, P.J. Bondon, F. Berthezene, et al.
Association between microsomal triglyceride transfer protein gene polymorphism and the biological features of liver steatosis in patients with type II diabetes.
Diabetologia, 43 (2000), pp. 995-999
[16.]
D.K. George, S. Goldwurm, G.A. MacDonald, L.L. Cowley, N.I. Walker, P.J. Ward, et al.
Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis.
Gastroenterology, 114 (1998), pp. 311-318
[17.]
A.J. Bathgate, V. Pravica, C. Perrey, G. Therapondos, J.N. Plevris, P.C. Hayes, I.V. Hutchinson.
The effect of polymorphisms in tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta1 genes in acute hepatic allograft rejection.
Transplantation, 69 (2000), pp. 514-517
Copyright © 2003. Elsevier España, S.L.. Todos los derechos reservados
